Literature DB >> 27105614

MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Yogita K Adlakha1, Neeru Saini2.   

Abstract

Resistance to apoptosis leads to tumorigenesis and failure of anti-cancer therapy. Recent studies also highlight abrogated lipid/cholesterol metabolism as one of the root causes of cancer that can lead to metastatic transformations. Cancer cells are dependent on tremendous supply of cellular cholesterol for the formation of new membranes and continuation of cell signaling. Cholesterol homeostasis network tightly regulates this metabolic need of cancer cells on cholesterol and other lipids. Genetic landscape is also shared between apoptosis and cholesterol metabolism. MicroRNAs (miRNAs) are the new fine tuners of signaling pathways and cellular processes and are known for their ability to post-transcriptionally repress gene expression in a targeted manner. This review summarizes the current knowledge about the cross talk between apoptosis and cholesterol metabolism via miRNAs. In addition, we also emphasize herein recent therapeutic modulations of specific miRNAs and their promising potential for the treatment of deadly diseases including cancer and cholesterol related pathologies. Understanding of the impact of miRNA-based regulation of apoptosis and metabolic processes is still at its dawn and needs further research for the development of future miRNA-based therapies. As both these physiological processes affect cellular homeostasis, we believe that this comprehensive summary of miRNAs modulating both apoptosis and cholesterol metabolism will open uncharted territory for scientific exploration and will provide the foundation for discovering novel drug targets for cancer and metabolic diseases.

Entities:  

Keywords:  Apoptosis; Cancer; Cholesterol; Metabolic diseases; Metabolism; miRNAs

Mesh:

Substances:

Year:  2016        PMID: 27105614     DOI: 10.1007/s13277-016-4988-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  297 in total

1.  Downregulation of miR-23a and miR-27a following experimental traumatic brain injury induces neuronal cell death through activation of proapoptotic Bcl-2 proteins.

Authors:  Boris Sabirzhanov; Zaorui Zhao; Bogdan A Stoica; David J Loane; Junfang Wu; Carlos Borroto; Susan G Dorsey; Alan I Faden
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

2.  miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.

Authors:  Kay Ka-Wai Li; Tian Xia; Fanny Man Ting Ma; Rong Zhang; Ying Mao; Yin Wang; Liangfu Zhou; Kin-Mang Lau; Ho-Keung Ng
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

3.  MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function.

Authors:  S Donzelli; G Fontemaggi; F Fazi; S Di Agostino; F Padula; F Biagioni; P Muti; S Strano; G Blandino
Journal:  Cell Death Differ       Date:  2011-12-23       Impact factor: 15.828

4.  MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.

Authors:  Wei-Chih Tsai; Paul Wei-Che Hsu; Tsung-Ching Lai; Gar-Yang Chau; Ching-Wen Lin; Chun-Ming Chen; Chien-Der Lin; Yu-Lun Liao; Jui-Ling Wang; Yat-Pang Chau; Ming-Ta Hsu; Michael Hsiao; Hsien-Da Huang; Ann-Ping Tsou
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

5.  Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.

Authors:  Clifton L Dalgard; Marco Gonzalez; Jennifer E deNiro; Joan M O'Brien
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

6.  Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

Authors:  Aparna Purushotham; Thaddeus T Schug; Qing Xu; Sailesh Surapureddi; Xiumei Guo; Xiaoling Li
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

7.  Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells.

Authors:  Jun Xia; Long Cheng; Chuanzhong Mei; Jia Ma; Ying Shi; Fanpeng Zeng; Zhenghuan Wang; Zhiwei Wang
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.

Authors:  Indira Jutooru; Aaron S Guthrie; Gayathri Chadalapaka; Satya Pathi; KyoungHyun Kim; Robert Burghardt; Un-Ho Jin; Stephen Safe
Journal:  Mol Cell Biol       Date:  2014-04-14       Impact factor: 4.272

9.  Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.

Authors:  Catarina Rodrigues Dos Santos; Isabel Fonseca; Sérgio Dias; J C Mendes de Almeida
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

10.  Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis.

Authors:  Godwin O Ifere; Renee Desmond; Wendy Demark-Wahnefried; Tim R Nagy
Journal:  Int J Oncol       Date:  2013-08-07       Impact factor: 5.650

View more
  8 in total

1.  Establishment of preliminary regulatory network of TRPV1 and related cytokines.

Authors:  Jianhua Zhang; Zheng Zhou; Ning Zhang; Wenwen Jin; Yafeng Ren; Chuanliang Chen
Journal:  Saudi J Biol Sci       Date:  2017-01-26       Impact factor: 4.219

2.  miR-128 Is Implicated in Stress Responses by Targeting MAFG in Skeletal Muscle Cells.

Authors:  Rocco Caggiano; Fabio Cattaneo; Ornella Moltedo; Giovanni Esposito; Cinzia Perrino; Bruno Trimarco; Rosario Ammendola; Raffaella Faraonio
Journal:  Oxid Med Cell Longev       Date:  2017-09-12       Impact factor: 6.543

3.  Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells.

Authors:  Ankit Sharma; Shreetama Bandyopadhayaya; Kaushik Chowdhury; Tanu Sharma; Rekha Maheshwari; Amlan Das; Gopal Chakrabarti; Vipin Kumar; Chandi C Mandal
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

4.  Jie-Du-Hua-Yu Granules Promote Liver Regeneration in Rat Models of Acute Liver Failure: miRNA-mRNA Expression Analysis.

Authors:  Tingshuai Wang; Na Wang; Rongzhen Zhang; Shaodong Huang; Hua Qiu; Fuli Long; Minggang Wang; Dewen Mao
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-30       Impact factor: 2.629

Review 5.  Lipid Metabolism and Cancer.

Authors:  Hui Cheng; Meng Wang; Jingjing Su; Yueyue Li; Jiao Long; Jing Chu; Xinyu Wan; Yu Cao; Qinglin Li
Journal:  Life (Basel)       Date:  2022-05-25

6.  MicroRNA-320 inhibits cell proliferation and invasion in breast cancer cells by targeting SOX4.

Authors:  Jun-Wen Bai; Xia Wang; Ya-Feng Zhang; Guo-Dong Yao; Hong Liu
Journal:  Oncol Lett       Date:  2017-09-27       Impact factor: 2.967

7.  The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7.

Authors:  Dominique Thuringer; Gaetan Chanteloup; Pascale Winckler; Carmen Garrido
Journal:  Oncotarget       Date:  2018-09-07

8.  Crizotinib induces apoptosis of lung cancer cells through JAK-STAT pathway.

Authors:  Hongmin Lu; Shibo Wu; Huafei Chen; Ying Huang; Guoqin Qiu; Lingxiang Liu; Yong Li
Journal:  Oncol Lett       Date:  2018-09-04       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.